Literature DB >> 1466469

Interaction of intrathecal morphine with bupivacaine and lidocaine in the rat.

J P Penning1, T L Yaksh.   

Abstract

The interaction in the rat between intrathecal morphine and local anesthetics (bupivacaine and lidocaine) on nociception (52.5 degrees C hot plate and paw pressure), motor function, and autonomic function (blood pressure [BP] and heart rate [HR]) was examined over a range of doses for both morphine and the local anesthetics. High doses of intrathecal bupivacaine (75 micrograms) or lidocaine (500 micrograms) produced motor block and hypotension (150 micrograms bupivacaine) lasting approximately 15 and 7 min, respectively, whereas low doses of intrathecal bupivacaine (25 micrograms) and lidocaine (100 micrograms) produced only a transient motor weakness lasting 2 min or less. Alone, neither agent altered the hot plate or paw pressure response at doses, or at times, where the agents had no effect upon motor function. In contrast, at the low dose of either local anesthetic, after the resolution of the transient motor weakness, these doses resulted in a significant leftward shift in the dose-response curves for intrathecal morphine on both the hot plate and paw pressure, as measured by the maximum observed peak effect and by the area under the time-effect curve. Thus, for example, the morphine ED50 (95% confidence intervals) for morphine/saline was 1.7 micrograms (0.7-1.9) on the hot plate and 1.1 micrograms (0.8-1.4) on the paw pressure versus for morphine/bupivacaine (25 micrograms): hot plate 0.25 micrograms (0.21-0.42) and paw pressure 0.28 micrograms (0.2-0.4). Intrathecal morphine was not observed to have any effect on the dose-dependent effects of intrathecal bupivacaine on motor or autonomic blockade. Comparable results were also observed with lidocaine (bupivacaine was found to have no significant effect on spinal cord morphine clearance). We conclude that low doses of intrathecal lidocaine and bupivacaine, which alone have no antinociceptive effect, at times when motor function was clearly unimpaired, are able to significantly augment the antinociceptive activity of intrathecal morphine on the hot plate and paw pressure tests. This prominent and selective potentiation appears to occur via a non-pharmacokinetic mechanism and probably reflects upon the interaction of low concentrations of local anesthetics with systems in the spinal dorsal horn that process acute high threshold afferent input.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466469     DOI: 10.1097/00000542-199212000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  Intrathecal therapy for chronic pain: current trends and future needs.

Authors:  Salim M Hayek; Michael C Hanes
Journal:  Curr Pain Headache Rep       Date:  2014-01

2.  Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States.

Authors:  Sarah A Woller; Soo-Ho Choi; Eun Jung An; Hann Low; Dina A Schneider; Roshni Ramachandran; Jungsu Kim; Yun Soo Bae; Dmitri Sviridov; Maripat Corr; Tony L Yaksh; Yury I Miller
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

Review 3.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Intrathecally administered NMDA receptor antagonists reduce the MAC of isoflurane in rats.

Authors:  K Ishizaki; N Yoshida; D M Yoon; M H Yoon; M Sudoh; T Fujita
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

5.  End tidal halothane concentration and postoperative analgesia requirements in dogs: a comparison between intravenous oxymorphone and epidural bupivacaine alone and in combination with oxymorphone.

Authors:  K E Torske; D H Dyson; G Pettifer
Journal:  Can Vet J       Date:  1998-06       Impact factor: 1.008

6.  A large animal neuropathic pain model in sheep: a strategy for improving the predictability of preclinical models for therapeutic development.

Authors:  Denise Wilkes; Guangwen Li; Carmina F Angeles; Joel T Patterson; Li-Yen Mae Huang
Journal:  J Pain Res       Date:  2012-10-25       Impact factor: 3.133

Review 7.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.

Authors:  Jose De Andres; Salim Hayek; Christophe Perruchoud; Melinda M Lawrence; Miguel Angel Reina; Carmen De Andres-Serrano; Ruben Rubio-Haro; Mathew Hunt; Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-16

8.  Effects of fadolmidine, an α2 -adrenoceptor agonist, as an adjuvant to spinal bupivacaine on antinociception and motor function in rats and dogs.

Authors:  Tiina Leino; Timo Viitamaa; Jarmo S Salonen; Ullamari Pesonen; Antti Haapalinna
Journal:  Pharmacol Res Perspect       Date:  2021-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.